Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 31 of 58, showing 10 Applications out of 576 total, starting on record 301, ending on 310

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

301.

ECCT/15/10/02  
    A non-randomized, open label, single dose, pharmacokinetics, safety and tolerability study of Captopril 50mgs in healthy Kenyan Adults.   
Principal Investigator(s)
1. Bernhards Ragama Ogutu
Site(s) in Kenya
KEMRI centre for clinical Research
 
02-12-2015 View

302.

ECCT/21/03/03   PrEP My Way
    A Novel PrEP Delivery System to Meet the Needs of Young African Women   
Principal Investigator(s)
1. Prof. Elizabet Ann Bukusi
Site(s) in Kenya
Kisumu
 
06-07-2021 View

303.

ECCT/21/06/02   VAT00008
    A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of age and older.   
Principal Investigator(s)
1. Videlis Nduba
Site(s) in Kenya
1. Kenya Medical Research Institute (Nairobi City county)
2. KEMRI/Walter Reed Project Research Center-Kericho (Kericho county)
3. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center-Kisumu (Kisumu county)
4. Ganjoni Clinic – Mombasa (Mombasa county)
5. KEMRI/CCR Partners in Health R&D (PHRD)-Thika (Kiambu county)
6. Kenya Medical Research Institute (Kisumu county)
7. Moi University Clinical Research Centre (Uasin Gishu county)
8. Aga Khan University Hospital-Nairobi (Nairobi City county)
9. KEMRI CCR-Butere County Hospital Site- Butere (Kakamega county)
 
02-08-2021 View

304.

ECCT/21/06/10   VAT00008
    A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of age and older   
Principal Investigator(s)
1. Kishorchandra Narsinh Mandaliya
Site(s) in Kenya
1. Kenya Medical Research Institute (Kisumu county)
2. KEMRI/Walter Reed Project Research Center (Kericho county)
3. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county)
4. KEMRI CMR (Kisumu county)
5. Kenya Medical Research Institute (Nairobi City county)
6. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
7. Moi University Clinical Research Centre (Uasin Gishu county)
8. Aga Khan University Hospital (Nairobi City county)
9. KEMRI CCR-Butere County Hospital Site (Kakamega county)
10. Ganjoni Clinic (Mombasa county)
 
16-08-2021 View

305.

ECCT/21/11/01   VAT 00008
    A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of age and older   
Principal Investigator(s)
1. Walter Godfrey Jaoko
Site(s) in Kenya
1. Kenya Medical Research Institute (Kisumu county)
2. KEMRI/Walter Reed Project Research Center (Kericho county)
3. KEMRI/CCR Partners in Health R&D (PHRD) (Kiambu county)
4. KEMRI CMR (Kisumu county)
5. Kenya Medical Research Institute (Nairobi City county)
6. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
7. Moi University Clinical Research Centre (Uasin Gishu county)
8. Aga Khan University Hospital (Nairobi City county)
9. KEMRI CCR-Butere County Hospital Site (Kakamega county)
10. Ganjoni Clinic (Mombasa county)
 
15-01-2022 View

306.

ECCT/21/06/07   VAT00008
    A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of age and older   
Principal Investigator(s)
1. Samuel Ouma Gurrion Ouma
Site(s) in Kenya
1. Kenya Medical Research Institute Kisumu Clinical Research Site (Kisumu county)
2. KEMRI/Walter Reed Project Research Center (Kericho county)
3. Ganjoni Clinic (Mombasa county)
4. KEMRI/CCR Partners in Health R&D (PHRD (Nairobi City county)
5. Kenya Medical Research Institute (Nairobi City county)
6. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
7. Moi University Clinical Research Centre (Uasin Gishu county)
8. Aga Khan University Hospital (Nairobi City county)
9. KEMRI CCR-Butere County Hospital Site (Kakamega county)
 
16-08-2021 View

307.

ECCT/21/06/04   VAT00008
    A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted  Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of ageand older   
Principal Investigator(s)
1. Lucas Otieno
Site(s) in Kenya
1. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
2. Kenya Medical Research Institute (Kisumu county)
3. KEMRI/Walter Reed Project Research Center (Kericho county)
4. Ganjoni Clinic (Mombasa county)
5. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county)
6. Kenya Medical Research Institute (Murang\'a county)
7. Moi University Clinical Research Centre (Uasin Gishu county)
8. Aga Khan University Hospital (Nairobi City county)
9. KEMRI CCR-Butere County Hospital Site (Kakamega county)
 
02-08-2021 View

308.

ECCT/21/06/06   VAT00008
    A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted  Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of ageand older   
Principal Investigator(s)
1. Janet Oyieko
Site(s) in Kenya
1. KEMRI CCR-Butere County Hospital Site (Kakamega county)
2. Kenya Medical Research Institute (Kisumu county)
3. KEMRI/Walter Reed Project Research Center (Kericho county)
4. Ganjoni Clinic (Mombasa county)
5. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county)
6. Kenya Medical Research Institute (Nairobi City county)
7. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
8. Moi University Clinical Research Centre (Uasin Gishu county)
9. Aga Khan University Hospital (Nairobi City county)
10. Kenya Medical Research Institute (Kisumu county)
11. KEMRI/Walter Reed Project Research Center (Kericho county)
12. Ganjoni Clinic (Mombasa county)
13. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county)
14. Kenya Medical Research Institute (Nairobi City county)
15. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
16. Moi University Clinical Research Centre (Uasin Gishu county)
17. Aga Khan University Hospital (Nairobi City county)
18. Kenya Medical Research Institute (Kisumu county)
19. KEMRI/Walter Reed Project Research Center (Kericho county)
20. Ganjoni Clinic (Mombasa county)
21. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county)
22. Kenya Medical Research Institute (Nairobi City county)
23. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
24. Moi University Clinical Research Centre (Uasin Gishu county)
25. Aga Khan University Hospital (Nairobi City county)
26. Kenya Medical Research Institute (Kisumu county)
27. KEMRI/Walter Reed Project Research Center (Kericho county)
28. Ganjoni Clinic (Mombasa county)
29. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county)
30. Kenya Medical Research Institute (Nairobi City county)
31. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
32. Moi University Clinical Research Centre (Uasin Gishu county)
33. Aga Khan University Hospital (Nairobi City county)
34. Kenya Medical Research Institute (Kisumu county)
35. KEMRI/Walter Reed Project Research Center (Kericho county)
36. Ganjoni Clinic (Mombasa county)
37. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county)
38. Kenya Medical Research Institute (Nairobi City county)
39. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
40. Moi University Clinical Research Centre (Uasin Gishu county)
41. Aga Khan University Hospital (Nairobi City county)
 
16-08-2021 View

309.

ECCT/20/10/01   HIV-CORE 006
    A Phase 1 Trial of ChAdOx1- and MVA-vectored Conserved Mosaic HIV-1 Vaccines in Healthy, Adult HIV-1-negative Volunteers in Eastern and Southern Africa.    
Principal Investigator(s)
1. Eduard J Sanders
Site(s) in Kenya
1. KEMRI Mtwapa Research Clinic (Kilifi county)
2. KAVI-ICR Nairobi (Nairobi City county)
 
19-11-2020 View

310.

ECCT/20/06/09   HIV-CORE 006
    A Phase 1 Trial of ChAdOx1- and MVA-vectored Conserved Mosaic HIV-1 Vaccines in Healthy, Adult HIV-1-negative Volunteers in Eastern and Southern Africa   
Principal Investigator(s)
1. Professor Walter Jaoko, Jaoko,
Site(s) in Kenya
1. KAVI-Institute of Clinical Research (Nairobi City county)
2. KEMRI/ Wellcome Trust Research Programme (Kilifi county)
 
09-09-2020 View